Earnings Feed
Start Free
Home/Filings/3/0001213900-21-009722
3//SEC Filing

LSV Associates, LLC 3

Accession 0001213900-21-009722

CIK 0001816736other
View on SEC.govCompany Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 5:23 PM ET

Size

17.3 KB

Accession

0001213900-21-009722

Insider Transaction Report

Form 3
Period: 2021-02-05
Gemini Therapeutics, Inc. /DEGMTX
LSV Associates, LLC
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    381,040

  • Common Stock

    (indirect: See Footnote)
    2,796,868

  • Common Stock

    (indirect: See Footnote)
    1,658,198
Lightstone Ventures, L.P.
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    1,658,198

  • Common Stock

    (indirect: See Footnote)
    2,796,868

  • Common Stock

    (indirect: See Footnote)
    381,040
Lightstone Ventures (A), L.P.
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    2,796,868

  • Common Stock

    (indirect: See Footnote)
    381,040

  • Common Stock

    (indirect: See Footnote)
    1,658,198
Lightstone Singapore, L.P.
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    1,658,198

  • Common Stock

    (indirect: See Footnote)
    2,796,868

  • Common Stock

    (indirect: See Footnote)
    381,040
Lightstone Singapore Associates, LLC
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    1,658,198

  • Common Stock

    (indirect: See Footnote)
    381,040

  • Common Stock

    (indirect: See Footnote)
    2,796,868
Carusi Michael A
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    2,796,868

  • Common Stock

    (indirect: See Footnote)
    381,040

  • Common Stock

    (indirect: See Footnote)
    1,658,198
Plain Henry A JR
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    2,796,868

  • Common Stock

    (indirect: See Footnote)
    381,040

  • Common Stock

    (indirect: See Footnote)
    1,658,198
Footnotes (3)
  • [F1]These shares are held by Lightstone Ventures, L.P. ("LV LP"). LSV Associates, LLC ("LSV Associates") is the general partner of LV LP. As the individual managing directors of LSV Associates, Michael A. Carusi, Jean M. George and Henry A. Plain Jr. share voting and dispositive power with respect to the shares held of record by LV LP. Each of LSV Associates, Mr. Carusi and Mr. Plain disclaim beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Ms. George, as a director of the Issuer, files separate Section 16 reports.
  • [F2]These shares are held by Lightstone Ventures (A), L.P. ("LV(A) LP"). LSV Associates is the general partner of LV(A) LP. As the individual managing directors of LSV Associates, Michael A. Carusi, Jean M. George and Henry A. Plain Jr. share voting and dispositive power with respect to the shares held of record by LV(A) LP. Each of LSV Associates, Mr. Carusi and Mr. Plain disclaim beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Ms. George, as a director of the Issuer, files separate Section 16 reports.
  • [F3]These shares are held by Lightstone Singapore, L.P. ("LV Singapore"), Lightstone Singapore Associates, LLC ("Lightstone Singapore Associates") is the general partner of LV Singapore. As the individual managing directors of Lightstone Singapore Associates, Michael A. Carusi, Jean M. George and Henry A. Plain Jr. share voting and dispositive power with respect to the shares held of record by LV Singapore. Each of Lightstone Singapore Associates, Mr. Carusi and Mr. Plain disclaim beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Ms. George, as a director of the Issuer, files separate Section 16 reports.

Documents

1 file

Issuer

Gemini Therapeutics, Inc. /DE

CIK 0001816736

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001643828

Filing Metadata

Form type
3
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:23 PM ET
Size
17.3 KB
View on SEC.gov